Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to $2.8 million.

  • Strata Critical Medical's Capital Expenditures fell 6960.35% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year decrease of 5311.29%. This contributed to the annual value of $30.9 million for FY2024, which is 136396.4% up from last year.
  • As of Q3 2025, Strata Critical Medical's Capital Expenditures stood at $2.8 million, which was down 6960.35% from $2.3 million recorded in Q2 2025.
  • Over the past 5 years, Strata Critical Medical's Capital Expenditures peaked at $16.2 million during Q2 2024, and registered a low of $11000.0 during Q4 2022.
  • Moreover, its 5-year median value for Capital Expenditures was $670500.0 (2023), whereas its average is $2.4 million.
  • In the last 5 years, Strata Critical Medical's Capital Expenditures plummeted by 9508.93% in 2022 and then soared by 1902083.33% in 2024.
  • Quarter analysis of 5 years shows Strata Critical Medical's Capital Expenditures stood at $224000.0 in 2021, then crashed by 95.09% to $11000.0 in 2022, then skyrocketed by 118.18% to $24000.0 in 2023, then soared by 19020.83% to $4.6 million in 2024, then tumbled by 38.35% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q3 2025, $2.3 million for Q2 2025, and $2.6 million during Q1 2025.